Zobrazeno 1 - 10
of 23
pro vyhledávání: '"B C, Pestalozzi"'
Publikováno v:
Der Chirurg. 76:570-574
Zusammenfassung: Die medikamentöse Behandlung des kolorektalen Karzinoms hat in den letzten 10Jahren eindrückliche Fortschritte gemacht. Neben dem altbewährten 5-Fluorouracil stehen heute neue Zytostatika zur Verfügung wie Irinotecan und Oxalipla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::078d7f9ce476064b1515e032be99a0c1
https://doi.org/10.1007/s00104-005-1038-6
https://doi.org/10.1007/s00104-005-1038-6
Autor:
A Knuth, B C Pestalozzi
Publikováno v:
Praxis. 93:1589-1592
Seit der Entwicklung der Hybridomtechnik 1975 können monoklonale Antikörper mit wählbarer Spezifität hergestellt werden. Erst zwanzig Jahre später gelang es, monoklonale Antikörper als Medikamente therapeutisch zu nutzen in der Onkologie. Zur V
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a8b88c2e7209daef97be88c8fd8a4c8
https://doi.org/10.1024/0369-8394.93.39.1589
https://doi.org/10.1024/0369-8394.93.39.1589
Publikováno v:
Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 77(12)
Until recently, cancer therapy was based on three modalities: surgery, radiotherapy, and cytostatic chemotherapy. In most instances treatment of solid tumors was a surgical domain. For patients with incomplete resection or relapse after surgery, radi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2c8686db1d3dc32d94ee8772405a60c9
https://pubmed.ncbi.nlm.nih.gov/17109101
https://pubmed.ncbi.nlm.nih.gov/17109101
Autor:
B C, Pestalozzi
Publikováno v:
Therapeutische Umschau. Revue therapeutique. 63(4)
The treatment of breast cancer has made significant improvements during the past ten years. For early breast cancer with a clinically negative axilla sentinel node biopsy has become the preferred approach. For endocrine therapy of postmenopausal pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::24b8f4d56eab121d04fe0fa0899c7478
https://pubmed.ncbi.nlm.nih.gov/16689456
https://pubmed.ncbi.nlm.nih.gov/16689456
Publikováno v:
Praxis. 94(33)
Adenocarcinoma of the pancreas (pancreatic cancer) is the most frequent tumor entity in the pancreas. While the results of surgical therapy of pancreatic cancer were disappointing in the past due to high perioperative mortality rates, resection of pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6ae0d1f726bf1600e0a22f7e22122934
https://pubmed.ncbi.nlm.nih.gov/16138769
https://pubmed.ncbi.nlm.nih.gov/16138769
Publikováno v:
Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 76(6)
Drug treatment of colorectal cancer has made impressive progress during the past 10 years. In addition to the traditional 5-fluorouracil, newer anticancer drugs are available including irinotecan and oxaliplatin. Monoclonal antibodies like bevacizuma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7ff8d856f13c5798d35352cd4917c334
https://pubmed.ncbi.nlm.nih.gov/15905968
https://pubmed.ncbi.nlm.nih.gov/15905968
Autor:
B C, Pestalozzi, A, Knuth
Publikováno v:
Praxis. 93(39)
Since the development of hybridoma technology in 1975 monoclonal antibodies with pre-defined specificity can be produced. Only twenty years later did it become possible to make therapeutic use of monoclonal antibodies in oncology. To this end it was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7164300eb2e2e9672ca425d8c2d21212
https://pubmed.ncbi.nlm.nih.gov/15500243
https://pubmed.ncbi.nlm.nih.gov/15500243
Publikováno v:
Praxis. 93(36)
Drug treatment of colorectal cancer has made impressive progress during the past 10 years. In addition to fluorouracil new anticancer drugs like irinotecan and oxaliplatin have become available. The activity of fluorouracil was optimized by using sch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8ad5680718fe95a3085eebd0a3fb7dcc
https://pubmed.ncbi.nlm.nih.gov/15487860
https://pubmed.ncbi.nlm.nih.gov/15487860
Publikováno v:
The British journal of surgery. 91(4)
Background Diagnostic and therapeutic options for hepatocellular carcinoma (HCC) have improved substantially in recent years. A number of new palliative and potentially curative treatment strategies are now available. However, evaluation of the thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36fc3f52e1a790350138719c819780ab
https://pubmed.ncbi.nlm.nih.gov/15286973
https://pubmed.ncbi.nlm.nih.gov/15286973
Autor:
C J, McGinn, B C, Pestalozzi, J C, Drake, M C, Glennon, K, Kunugi, G, Otterson, C J, Allegra, P G, Johnston, T J, Kinsella
Publikováno v:
Cancer journal (Sudbury, Mass.). 6(4)
Resistance to 5-fluorouracil (5-FU) has been associated with thymidylate synthase (TS) gene amplification and increased TS protein levels. Increased TS protein expression has also been found to be a significant independent prognostic factor for disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a30d7956f72ca1eb76d55178773f4fb2
https://pubmed.ncbi.nlm.nih.gov/11038140
https://pubmed.ncbi.nlm.nih.gov/11038140